Please login to the form below

Research Partnership

Research Partnership : Global pharmaceutical market research Research Partnership is the largest independent healthcare market research and consulting agencies. We’re trusted by the global pharmaceutical industry to provide the intelligence they need to flourish in an environment that’s becoming ever more challenging.

We work solely in healthcare, where our expertise and passion are unparalleled. Because we are independent, we can provide a truly bespoke service, managed by our large and experienced senior team and supported by our talented pool of professionally-trained researchers.

What we deliver goes beyond research. Our clients see us as a valued partner working to resolve their business challenges, providing strategic recommendations and brand roadmaps to help them optimise their budgets and maximise their competitive edge.

Areas of Expertise

Using the full range of qualitative and quantitative techniques, we specialise in custom research and consultancy.

Prescription medicines
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.

Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients and consumers to deliver integrated insights.

Medical devices and diagnostics
Our experience covers everything from insulin pens to large-scale surgical systems. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.

From market understanding, forecasting and landscaping, through ideation, concept testing, product and brand development, profiling, communications testing, launch and tracking, we support pharma through the lifecycle of the brand.

Team

Mark Jeffery Founding Director contact@researchpartnership.com	Mary Assimakopoulos Founding Director contact@researchpartnership.com View LinkedIn profile
Harriet Kozak US President harrietk@researchpartnership.com	Marc Yates Director, Emerging Markets marcy@researchpartnership.com View LinkedIn profile
PeiLi Teh Director, Singapore peilit@researchpartnership.com View LinkedIn profile

Press Releases

Research Partnership announces several new appointments: Research Partnership is delighted to welcome Anne Cunningham and Morten Andersen and announce that Sue Rees has joined our specialist Emerging Markets team.
Research Partnership appoints Helen Parfitt as Director, Head of Therapy Watch: Helen Parfitt has joined Research Partnership as Head of Therapy Watch at the company’s global head office in London. Therapy Watch is a ‘real-time’ syndicated global market tracking tool that provides the pharmaceutical industry with strategic and tactical market information on their brands.
Research Partnership is expanding its US capabilities with new offices opening in San Francisco and New York: Research Partnership is today expanding its US operations across both the West and East Coast. Director Tom Winter has relocated from London and is today opening a new office in San Francisco, to better service West Coast clients.

White Papers and Resources

Live webinar: Optimise your digital assets with UX research: Thursday 25th October 2018 11:00 EDT / 16:00 BST / 17:00 CEST
Rare diseases and orphan drugs: Our experience and expertise
Conducting research for publication video
Conference research case study: How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event
Portfolio analysis: Using market research to master communications across a therapeutic category
EphMRA round up 2018: EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.
Patients’willingness to pay: Considerations when developing an appropriate pricing strategy in self-pay markets
Research Partnership launches new patient Living with Diabetes (LATAM) 2018 report
Scratching the surface: unmet needs in psoriasis
Shift to preventative healthcare - Opportunities for screening, diagnostics and vaccination
Conference Live for ongoing congress performance measurement: Director John Branston discusses the benefits of a mobile approach for evaluating medical conferences year-on-year
Eyeforpharma Real World Evidence Conference Round up 2018
EphMRA Annual Conference 2018: Visit us on stand number 20
Live from Singapore: Full speed ahead - Unlock the full potential of your brand tracking: Thursday 28th June 16:00 SGT/ 16:00 CST / 17:00 JST
Connected Patients - Adopting a patient-centric approach in emerging markets
Combination therapies in oncology: The benefits of integrated insights: 14 June 2018 11am EDT | 8am PDT | 4pm BST | 5pm CE
Intellus round up 2018: Earlier this month, US President Harriet Kozak and Emerging Markets Director Rachel Howard attended the inaugural Intellus Worldwide Summit in Philadelphia
Janssen & Research Partnership win prestigious BHBIA Best Business Impact award
How published research underpinned a cancer therapy awareness campaign
How integrated insights supported a biologic launch strategy across multiple indications
How a hybrid approach delivered fast insights to feed into an oncology product’s adoption strategy
Oncology experience & expertise: Did you know 25% of our business is in Oncology?
First, we need to talk: mental healthcare in the MENA region: In our final installment of articles exploring mental health in emerging markets, we take an in-depth look at the situation in the MENA region
Atopic Dermatitis — Going Beyond the Pill: Published in Pharma Exec April 2018 by Mariel Metcalfe
ESOMAR Asia Pacific 2018: 13-15 May, Bangkok
Eyeforpharma – Real World Evidence 2018: 16-17 May in Tokyo, Japan
Intellus Worldwide Summit 2018: Visit us on stand number 413
How buyer insights supported the development of an effective market strategy
Conducting market research for scientific publication guide
Therapy Watch appoints new Associate Director
Sabera Hyderally appointed Head of MedTech North America: Research Partnership is delighted to welcome Sabera Hyderally who has joined the company’s US headquarters in Philadelphia.
Full speed ahead: Unlock the full potential of your brand tracking: Wednesday 2nd May 2018 10:30 EST / 15:30 GMT / 16:30 CEST
Dan Coffin joins London Headquarters as Director: Research Partnership is delighted to welcome Dan Coffin who has joined the company’s global head office in London
How scenario testing helped assess demand for a brand launch in the fragmented NSCLC market
Research Partnership and Janssen are 2017-18 BOBI Awards finalists
Portfolio analysis: Making Go/No-Go decisions to optimise the portfolio: Tuesday 20th March 2018 11:00 EST / 16:00 GMT / 17:00 CEST
PMRC New Jersey round up 2018: Earlier this month, Directors Tom Nolte and Melinda Shorr attended the Pharmaceutical Market Research Conference in Newark, New Jersey
Bringing sufferers out of the shadows – Reducing the emotional impact of living with Atopic Dermatitis
Good intentions, bad habits: Reforming mental healthcare in Latin America and the Caribbean: In the second of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Latin America and the Caribbean
How we applied user-led design thinking in the ER setting to improve patient care
Research conducted by Research Partnership published in leading medical journal: Findings from a study conducted by Research Partnership have recently been published in the ‘Supportive Care in Cancer’ journal
Webcast: Rich in potential - Exploring the opportunity for nutritionals in emerging markets
A researcher’s guide to Key Driver Analysis: Research Manager Kayleigh Simpson explores how Key Driver Analysis can be used to answer key business
Research Partnership sends a cheque for $10,000 to Forever Angels: Helping them in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania
Pharma Market Research Conference, 2018: We are delighted to be presenting and exhibiting at PMRC, 14-15 February in Newark, NJ.
Out of the shadows: Mental health in the Asia Pacific region: In the first of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Asia
Research Partnership has published a new patient Living with Atopic Dermatitis (US) report
Research Partnership has published a new patient Living with Psoriasis (EU) report
New opportunities in emerging markets: Published in Pharma Exec January 2018 by Rachel Howard
Research Partnership opens new office in Lyon, France: Research Partnership is very pleased to today announce the opening of a new office in Lyon, France, led by Associate Director Claire Fradet-Aubignat.
Webinar: Portfolio tracking for success: Thursday 18th January 2018 11:00 EST / 16:00 GMT / 17:00 CEST
20 questions: Round-up video
Patient centricity: Reality or rhetoric?: Everybody is talking about patient centricity, but what does it mean for those involved in market research, insights and business intelligence?
Review of Disease Promotion Campaign using Facial Analysis
Emotional Recognition using Facial Analysis
Living with NASH: An Unexpected Diagnosis: Published in eyeforpharma November 2017 by Mariel Metcalfe
20 questions: Round 7
Innovation, sustainability and prosperity: Japan’s healthcare vision for the future
Tools to action your segmentation: Our tools for ensuring a successful segmentation rollout
Research Partnership launches new patient Living with Atopic Dermatitis (US) 2017 report
The value of design thinking: Incorporating creative and graphic design into pharma market research
Research Partnership launches new patient Living with Psoriasis 2017 (EU) report
Deep Dive - MINT: opportunities in ‘frontier’ markets?
Webcast: Going for growth - Maximising your return on insights in Emerging Markets
20 questions: Round 6
Ageing Asia: What does this mean for the future of healthcare?
Punching above your weight: Combining behavioural and attitudinal data to strengthen segmentations
Qualitative segmentation validation study with backroom brainstorm exercises
PMRC EU, Düsseldorf 2017
Device Attribute Testing
Research Partnership welcomes 20 new Graduates
Corporate Equity Survey
Webcast: Capturing the “moments-of-truth” using online communities and bulletin boards
Research Partnership has published a new Living with Ulcerative Colitis (UC) US market report for 2017
20 questions: Round 5
Research Partnership publishes 2017 Living with NASH report
Blending qual and quant – the benefits of a hybrid approach
Multi-level Segmentation Solution
Global health care specialists from coast to coast: Published in Quirk's Faces of Marketing Research August 2017
Demand assessment research video
Men vs Women in emerging markets: Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS
South Korea: The next global player?
20 questions: Round 4
Will gene therapies finally be commercially viable to pharma?
Wargaming in HCV
Living with Lupus: Breaking the Silence: Published in eyeforpharma July 2017 by Mariel Metcalfe
Demystifying human-centred design: the application of iterative, human-centric approaches in global health market research
In the news: What will the UK’s recent general election result and ongoing Brexit negotiations mean for DfID funding for global health?
EphMRA 2017 round up: We were delighted to present, exhibit and sponsor this year’s EphMRA Annual Conference in Amsterdam, Netherlands.
Taking a hybrid qualitative-quantitative approach to research
20th anniversary celebrations
Pharma CI Asia Conference & Exhibition 2017: 13-14 July 2017, Singapore
Director Richard Head is joint winner of the 2017 EphMRA President's Award: We are delighted to announce that Research Partnership’s Richard Head is joint winner of the 2017 EphMRA President's Award for his contribution to pharmaceutical market research
Forever Angels founder is awarded an MBE
Research Partnership’s Singapore team relocates to new office: We are delighted to announce that our Asia-Pacific team in Singapore has relocated to new premises.
Nutrition Market in Brazil: Growth Against the Odds: Published in eyeforpharma June 2017 by Marc Yates
Research Partnership launches new patient Living with Ulcerative Colitis (UC) US report
Research Partnership is celebrating 20 years in business
Therapy Watch expands oncology and IBD portfolios: This month Therapy Watch expands its portfolio with the launch of several new trackers across numerous therapy areas including the launch of a new Chronic Myelogenous Leukaemia (CML) study in the US.
PMRC San Francisco 2017
EphMRA Annual Conference 2017: Visit us on stand number 14
Richard Head nominated for EphMRA Award
Research Partnership launches new patient Living With Non-alcoholic Steatohepatitis (NASH) report
EULAR Annual European Congress of Rheumatology 2017: Join us at EULAR Congress 2017 in Madrid, 14-17 June
20 questions: Round 2
Taking an integrated approach to research
Online Community Research: What to consider when running an online research community?
A safe place to talk about Crohn’s: Published in eyeforpharma April 2017 by Mariel Metcalfe
Patient Assistance Programme Evaluation for Cardiovascular Conditions
What next for the treatment of Psoriasis in Europe?: Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.
20 questions: Round 1
Brand tracking research
Pharma China Annual Forum 2017: We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.
Healthcare Market Research in the Gulf: 3 lessons I’ve learned: A few key considerations for conducting healthcare market research in the Gulf
Case study: Multiple Sclerosis new medical device research
Patient Centricity: Turning Rhetoric into Reality: Live webinar: Thursday 30th March 10:00 EDT / 15:00 BST / 16:00 CEST
Making sense of Nutraceuticals in China: Published in eyeforpharma February 2017 by Marc Yates
Research Partnership has been ranked in the Pharma Times Pharma Fast 50
Women's health in emerging markets
Research Partnership has published a new Living with Lupus (SLE) market report for 2017: SLE is a progressive and debilitating disease which affects 5 million people worldwide.
Cool heads in a crisis?: Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics
Biosimilars: Bringing patients into the conversation: Published in eyeforpharma January 2017 by Mariel Metcalfe
Access and elimination: the future of DAAs in hepatitis C: Published in Pharmaphorum January 2017
EphMRA One Day Meeting: We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London
Video: Segmentation research
Pharmaceutical Market Research Conference 2017: We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.
Shifting perceptions of the use of probiotics in IBS Management
Nutraceuticals in India: A Challenging Opportunity: Published in eyeforpharma December 2016 by Marc Yates
Research Partnership makes annual donation to Forever Projects: Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects
A Bitter Pill?: The ideal route of admin isn’t clear cut in the global marketplace
Understanding the chronic disease patient journey in emerging markets
Infographic: Keeping tracking on track: Our best practice approach to tracking studies.
Telehealth Research: The remote exchange of data between patients and their clinician
Case Study: Understanding the patient journey and addiction treatment pathways
Research Partnership has published a new Living with Chronic Pain market report for 2016
Nutraceuticals: Rich in Potential: Published in eyeforpharma October 2016 by Marc Yates
Case Study: Qualitative research with payers in low and middle income countries
Webinar - Immuno-oncology's Evolution: Implications for Pharma Market Researchers: In association with PMGroup
Case study: Leveraging Market Research Data to Inform Healthcare Providers and the Community
Towards a culture of evaluation and evidence-based decision making in global health: Reflections on THET Conference 2016: Evidence, Effectiveness & Impact
Research Partnership has published a new Living with Ulcerative Colitis (UC) market report for 2016
The Internet of Things: Evolution from man to machine
Therapy Watch expands its oncology portfolio
Time for a new language for asthma?
Evaluating the impact of your medical congress presence…more cost effectively
Delivering multi-stakeholder patient journey insights in oncology with creative outputs and data visualisation
Webinar: Understanding Patient Willingness to Pay: What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?
Research Partnership welcomes 22 new Graduates
Case study: Tracking a product launch in a dynamic and competitive market
Understanding the Chronic Disease Patient Journey in Emerging Markets
Latest wave of Therapy Watch IBD to run this month: The IBD syndicated market tracker is part of our large auto-immune portfolio
Research Partnership launches new patient report - Living with Lupus (SLE)
Webinar: Ensuring an Actionable Segmentation
Interactive infographic: LATAM: An overview of the six most-commonly researched, largest pharma markets in Latin America
Immuno-oncology: The market opportunity for PD-1/PD-L1s
Case Study: Using ‘Journey to the Future’ projective techniques to understand evolving customer expectations
Free Thinking - US Presidential Election: The legacy of the Affordable Care Act and the future for healthcare: Our latest Free Thinking white paper explores the legacy of the Affordable Care Act and the future for healthcare
Therapy Watch market snapshots
Case Study: Private market opportunity for a travel vaccine
Infographic: Conference Live
Blog: The Cost of Counterfeits: The sale of counterfeit drugs is growing at twice the rate of legitimate pharmaceuticals and pharma companies stand to lose more than just profits from the fallout of counterfeit identification.
Video: Self-pay and Emerging Markets
News: Therapy Watch HCV expands into 4 additional EU markets
News: Research Partnership launches new patient report - Living with Ulcerative Colitis
Summer Intern experience at Research Partnership: We look for bright and inquisitive people who want to learn in a company that's pushing the boundaries of pharmaceutical market research
Beyond Andrology: Trends in Men’s Health in Emerging Markets: Published in eyeforpharma July 2016 by Rachel Howard
Infographic: HIV Market Snapshot
Infographic: The vaccine opportunity in Asia
Webinar: What next for biosimilars?: Tuesday 19th July 15:00 BST/10:00 EDT/16:00 CEST
Understanding the Patient Journey
Case Study: Oncology diagnostic biomarker landscaping study
Research Partnership publishes 2016 Living with RA reports: Research Partnership has published new Living with rheumatoid arthritis (RA) EU and US market reports for 2016.
Article: The Art of Storytelling in Pharma Market Research: Published in PBIRG Perspective, May 2016, vol. 18 No.1, By Julie Denny, Marketing Director
Video: Immuno-oncology therapies
The challenges of conducting effective pharmaceutical market research in emerging markets: Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets
Research Partnership appoints Director and Head of Business Analytics, North America
Article: The Art of Storytelling in Pharma Market Research: Published in PBIRG Perspective, May 2016, vol. 18 No.1, By Julie Denny, Marketing Director
Event: EphMRA Annual Conference 2016: Frankfurt, Germany 21 - 23 June 2016
The challenges of conducting effective pharmaceutical market research in emerging markets: Published in Quirk's Marketing Research Review, April 2016, By Marc Yates, Director of Emerging Markets
Blog: Viewing facility research, re-imagined: As technology has evolved, so too has the world of qualitative research
Video: Immuno-oncology therapies
Event: EULAR Annual European Congress of Rheumatology 2016
Forever Angels achievements and development plan for 2016: Research Partnership is proud to support Forever Angels in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania
The Opportunity for Women’s Health in Emerging Markets: Published in eyeforpharma April 2016 by Rachel Howard
Video: Storytelling in healthcare market research
Promotions and new appointments across our global offices: Research Partnership is delighted to announce promotions and new starters in the UK and further appointments in the US and Singapore offices
Free Thinking: Are biosimilars the answer to the rising cost of RA treatment?
Webcast: Understanding the Chronic Disease Patient Journey in Emerging Markets: In emerging markets where primary care systems do not exist, the patient is the only constant in the journey
Living with Crohn's Report: Are you looking for a deeper understanding of the emotional needs, behaviours and treatment programmes of patients living with Crohn’s Disease?
Infographic: Research Partnership: Our latest infographic offers an overview of some key facts and figures about the company, its services and capabilities.
AAD conference 2016: Therapy Watch recently presented “real-world” patient data on treatment duration and persistence among European PsO patients
Video: Global Biosimilars Market: Research director of Therapy Watch, Laurent Chanroux, discusses the growth opportunities for biosimilars and the importance of adaptable market tracking for pre and post product launch
Case study: Understanding Patient Willingness to Pay in Emerging Markets
From promise to practice: immuno-oncology in action Part 3 - Emerging Markets: Our latest white paper on immuno-oncology explores the challenges and opportunities in emerging markets, with a focus on Asia.
Infographic: HCV EU
Taiwan: Exploring the Healthcare Opportunity in this Singular “Hybrid” Market: Published in eyeforpharma February 2016 by Rachel Howard
Gaining deeper insights within a hard to reach audience
Living with RA Report: Living with Rheumatoid Arthritis 2016 is a new syndicated report which offers low-cost, high-value quantitative insight into patient attitudes and behaviour.
Heather Desmet appointed new Head of Living With: We are delighted to welcome Heather Desmet as Head of Living With at the company’s London headquarters.
Webinar Recording: The Art of Storytelling in Pharma Market Research
Video: Conducting mobile conference research: Our digital expert, Director John Branston explores how a mobile approach offers a better way of evaluating the impact of your conference presence
Free Thinking: From promise to practice: immuno-oncology in action
Video: Syndicated patient record data: Track the global market in real time
Video: Patient level prescribing decisions
Pharma Market Research Report - Predictions for 2016: PMR invited US President Harriet Kozak to submit her predictions for 2016
Pharmaceutical Market Research Conference 2016
Nicole Bender Moreira promoted to Associate Director, Singapore office
New appointments announced across Research Partnership’s global offices: We are delighted to welcome Marianne Jaeger as Associate Director to our London headquarters
What to Consider When Conducting Patient Research in Saudi Arabia: The need to understand the patient as a key stakeholder is now recognized by pharma across the globe.
Research Partnership hires Graphic Designer to create storytelling deliverables
Research Partnership is UK’s fastest growing healthcare market research specialist
Emerging Markets: Your Essential Guide
Free Thinking: From promise to practice: immuno-oncology in action
Exploring the Opportunity For Halal In Healthcare: Published in Medical Marketing & Media November 2015
Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets: Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets
12 Challenges Big Pharma Faces in China: Published in eyeforpharma 16 November by Rachel Howard
Using mobile “diary” research to capture patient-generated insights in COPD: Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients
Biosimilars in 2018: EU doctors’ perceptions of RA drug market: Published in pharmaphorum October 2015 by Laurent Chanroux
Webinar: Understanding the Patient Journey in China 2015: Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.
Understanding Patient Willingness to Pay: Published in eyeforpharma 12 October by Rachel Howard
Infographic: Spondyloarthritis: Overview of spondyloarthritis patient profiles and treatment pathways.
Webinar: Demand assessment - Reflecting real world choices: How study design which reflects doctors’ real world choices can optimise results.
Evaluating the potential of a pre-launch prodct in a real-life setting: Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.
Competition from within: Published in eyeforpharma July 29 by Rachel Howard
Infographic: RA Perceptions: HCPs predict the future of the biologics market
From chaos to calm: how to make sense of social media: What do you know about chaos theory?
Could ‘around the pill’ solutions be the key to effective diabetes management?: Published in pharmaphorum July 2015 by Julie Denny
Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America: Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.
Infographic: HCV LATAM: An introduction to the HCV LATAM patient.
Spotlight on Saudi Arabia: Published in eyeforpharma 20 May by Rachel Howard
Infographic: North Asia: An overview of the five most-commonly researched, largest pharma markets in North Asia.
Infographic: PsO market snapshot
Infographic: Prostate Cancer Market Snapshot
Infographic: LATAM
Infographic: RA market snapshot
Infographic: CEE
Infographic: ASEAN-6
Infographic: HCV - The Roadblocks to Effective Treatment
Turkey: Identifying the Growth Drivers: Published in eye for pharma 3 April by Marc Yates
Article: The Patient Abroad: Published in Medical Marketing & Media March 2015
A guide to measuring and tracking brand KPIs: Dr Allison Fleetwood, Director of Therapy Watch, alongside Associate Director Jennifer Redfearn, recently delivered a workshop on measuring and tracking brand KPIs as part of the BHBIA training programme (www.bhbia.org.uk).
Electronic medical records and doctor/patient communication: View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.
Statistics and bikinis – 2 men united: I want to write today about 2 men that between them have reminded me of a fine line that we have to tread every time we analyse a dataset...
Eliminating Stigma: A consideration of the role the pharmaceutical industry can play
Fighting talk: One thing that grasps my interest is how society has adopted military style language when talking about cancer
Is MINT the next BRIC?: In 2001, British economist Jim O’Neill coined the now ubiquitous acronym ‘BRIC’, to stand for the four emerging economies of Brazil, Russia, India and China, which he suggested were all poised for massive economic growth. Earlier this year, O’Neill came out of retirement to generate buzz about ‘MINT’ – that’s Mexico, Indonesia, Nigeria and Turkey to the uninitiated – as the next generation ‘ones to watch’ in the coming twenty years.
The healthcare market research themes for 2014: As we shake off our winter coats and prepare for what will hopefully be a long, hot summer, the 2014 themes for healthcare and market research are emerging.
Big Data—a new player in the Healthcare Industry: Big Data is an exciting by-product of the information technology revolution and offers new ways of understanding customers.
Blog: Affordable Care Act: What does the future hold for the US pharma industry?
Webinar: How to conduct effective market research in emerging markets: Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.
Webinar: Uncovering hidden insights into patient compliance
Webinar: The patient journey: Time to look beyond the physician?: Treatment initiation is a key focus for many pharma companies as part of their strategy to increase script writing and drive greater revenues.
Webinar: Ensuring an actionable segmentation: One of the most consistent issues researchers face with segmentation is ensuring that it is actionable.
Webcast: Leveraging the ASEAN opportunities: Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.
Webcast: Biosimilars: Friend or Foe to Healthcare?: Understanding the opportunities for biosimilars and the threats to innovator biologics
Webinar: Understanding the patient journey in China: The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and considers the possible implications for market researchers.
Webinar: Capturing "in-the-moment" patient and physician insights: Utilising the benefits of mobile technology
Webinar: Observational Research: Presenting a window on the world of your customer
Webinar: The Brazil Conundrum: Conducting research in one of the world's largest pharma markets
Webinar: Demand calibration: What's inside the black box?: The process of demand calibration of preference share (down-weighting) is often a proprietary "black box" technique, which can mean that the client is unsure how the calibrated figure has been reached.
Free Thinking: Behavioural economics: Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Article: The Colombia Conundrum: Published in eye for pharma 30 January by Marc Yates
Ageing in China: The Implications for Healthcare: Published in eye for pharma 12 December by Marc Yates
5 years on from the Brazilian Generics Drugs Act, is there still an opportunity for branded originator drugs?: Published in Eye for Pharma 10 November by Marc Yates
Exploring MINT: Part 4 - Turkey: In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Turkey.
Getting to grips with Russia’s healthcare market: As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't exist.
Exploring MINT: Part 3 - Nigeria: In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.
Exploring MINT: Part 2 - Indonesia: In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with a focus on the impact of its planned roll-out of a universal healthcare system.
Free Thinking: Leveraging the ASEAN Market: If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to consider in deciding which markets to research.
Free Thinking: Biosimilars: Friend or foe to healthcare?: Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.
The Next Billion Patients: Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
Huge Untapped Growth Potential of ASEAN: Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
The Untapped Potential of ASEAN: The key growth factors: In part 2 of the ASEAN series, Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
Exploring MINT: Part 1 - Mexico: In the first of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Mexico.
The power of observation in gathering patient insights: Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding.
Market Insights Can Deliver a Better Patient Experience: Mary Assimakopoulos, Founding Director of global pharma market research specialist Research Partnership discusses how pharma can benefit from improved patient understanding
Excellence in oncology: Developing an effective biomarker strategy: Oncology is arguably the most exciting area of medicine in which to be working today. Biomarkers and companion diagnostics offer incredibly valuable predictive power, which is of benefit to payers, physicians and patients.
The cost of being a caregiver: There is now a concerted effort on the part of the leading pharma manufacturers to try to understand patient needs as much as the needs of physicians
Warehousing of HCV patients reaches new high: A new study conducted by Research Partnership reveals that 90% of physicians treating HCV patients in the US have reported they are now “warehousing” patients (holding off treatment) in expectation of more efficacious and tolerable new therapies.
Brand leaders in RA will lose market share, predict rheumatologists: Rheumatologists believe that the current market for biologic treatments in Rheumatoid Arthritis (RA) will see key changes in the next three years.
Patients in China: the Silent Stakeholder: This month Mary Assimakopoulos, talks about the issues around healthcare access for patients in China and highlights some of the adherence issues unique to the region.
Removing the Roadblocks to Effective Patient Treatment: How can pharma benefit from improved patient understanding? Welcome to a new column in which Mary Assimakopoulos, Founding Director of pharma market research specialist the Research Partnership reveals findings from the patient research series “Living with chronic illness”.
Driving Earlier Diagnosis: A Case Study in Psoriatic Arthritis: Following a survey of 1000 Psoriatic Arthritis patients, Mary Assimakopoulos shares some of the root causes behind a late diagnosis of this debilitating illness, and the patients’ own feelings towards their standard of care.
Patient Compliance – Cracking that Big Nut!: In this month’s column we look at the issue of non-adherence, the risk of bias in adherence surveys and how a better understanding of true patient behavior is critical to improving compliance.
Comparing East vs West in Hep C Patient Understanding: In this month’s column we look at Hepatitis C and examine the differences (and similarities) between the causes of non-adherence in China and the US
The Difficulties of Living with Depression Don't End with the Illness Itself: This month Mary Assimakopoulos examines some of the insights gathered while surveying 2,000 patients suffering with this often misunderstood mental illness.
Patient Power: Too Much of a Good Thing?: Mary Assimakopoulos, reveals findings from the company’s Therapy Watch market research data, investigating patient behaviour in Crohn’s Disease and discusses how pharma can benefit from improved patient understanding
Barriers to Biologic Treatment - Is Injecting Such a Pain?: Mary Assimakopoulos examines a common yet often unaddressed patient concern – the very human fear of needles!
China's Chronic Disease Challenge: 260 million people from mainland China now suffer from a chronic disease condition such as diabetes because of lifestyle factors including smoking, lack of exercise and a high-fat diet. Apart from the particularly high smoking rate, most other developed nations have similar risk profiles. Yet the World Health Organisation (W.H.O) reports that 85% of deaths each year in China are from chronic illness, significantly more than anywhere else in the developed world. Why is this?
Webinar: Mobile Research in Asia and Emerging Markets: Current statistics around mobile technology reveal that many physicians in Asia are now using smartphones, tablets and other mobile devices to assist them in their daily practices. In China alone,73% of physicians regularly use mobile devices to make clinical decisions. With use of three client case studies, this webinar looks at the benefits of conducting mobile research amongst physicians and patients in Asia and the emerging markets.
Webinar: Reinventing Conference Research Using Mobile Technology: With the use of a real-life customer case study, this short 15 min webinar recording will describe the opportunities presented by mobile technology in a conference setting and how this new methodological approach can offer a superior way of eliciting delegate insights
Webinar: Understanding the Patient Journey in Order to Influence Prescribing Decisions: Using real data, this webinar looks at the increasingly popular view that says we need to understand more about the patient and the relationship they have with their physicians in order to really influence prescribing decisions and improve outcomes.
Webinar: Focus on China: Conducting Research in the World’s Fastest Growing Pharma Market: This webinar looks to provide market research professionals with an overview of the Chinese healthcare market and provide participants with top tips for conducting relevant and effective market research in the region.
Webinar: Prescription Rationale: Physician Research via an iPhone App: This webinar explores the potential of using smartphone Apps as a platform for collecting detailed qualitative insights into physicians' decision rationale at the moment of prescription.
Maximising patient adherence by leveraging the patient/ physician/ pharma relationship: Director Marc Yates looks at the problem of patient compliance - can a better understanding of patient attitudes, needs and behaviours help pharma develop strategies to improve adherence?
Digital research in Asia: Director Marc Yates uses findings from a study conducted in six markets in Asia to explore how digital channels are being utilised by consumers and look at the digital opportunities for marketers.
Achieving customer centricity - Using immersion techniques to get closer to the pulse of the customer: Director Marc Yates discusses the importance of being customer-centric in the pharmaceutical industry and how immersion techniques in market research can help develop a better understanding of the customer.
The Mobile Revolution - Using mobile Apps to deliver “in-the-moment” market research to global healthcare: Director John Branston investigates the use of mobile research in order to capture immediate detailed, qualitative insights into prescription rationale at the patient level.

Latest Tweets

Tweets by @RP_news

Facebook

Testimonials

http://www.researchpartnership.com/who-we-are/-satisfaction/

"The team did an excellent job designing, executing, and synthesizing the data & insights from this study. It was a challenging project involving a large number of countries and in the end the team put together very thorough reports and a concise summary. The input during the design of the quant survey was also very valuable and ensured the right type of data was collected."
Director, Commercial Planning & Operations"I just want to thank you for the recent project you ran very successfully. The report delivered was high quality, definitely bringing new insights and ways to look at our marketing issue. It was also clear at the presentation that you had a deep understanding of the disease area. Very good job!"
Director, Business Analysis"Your results have driven key decision making which is now translating into very good performance for our brand, so well done."
Commercial Analysis Manager
"I would like to thank all of you for the excellent work you did and all the support provided. Your expertise and professionalism was highly appreciated, as were the provided results. I’m already looking forward to the next possibility to work with you"
International Business Analyst

"I just wanted to tell you how impressed I continue to be with the team at Research Partnership. They never seem to tire, take copious notes and remain engaged each and every day. It has certainly been a pleasure working with the team and I look forward to a continued partnership!"
Associate Director, Global Marketing Science